How does it work?
Patients are asked to participate in a clinical trial by their doctor. If a patient consents, left over fresh tumor tissue is collected from routine diagnostic procedures and transported to VitroScan in Leiden.
Upon arrival in the laboratory the tissue is processed, seeded into assay plates, and exposed with standard of care and novel drugs. After a few days the plates are imaged, analysed and the sensitivity of the tumor tissue to the different drugs is quantified. At this stage in development the results are used to validate the testing, and reports are not yet used for guiding treatment decisions.
Clinical trial program
VitroScan’s Predictive Tumor Testing Platform is in clinical development for multiple solid tumors. We closely collaborate with expert clinicians, pathologists, and leading cancer centers to establish the value of our tumor testing services for patients, doctors, and the health care system.
VitroScan is performing correlation studies to train algorithms and prediction models and connect the results to clinical standards. For ovarian, lung and bladder cancer established correlation have been established for chemo-, targeted, and immunotherapies. Data are presented at conferences and will be published in scientific journals.
Closer to the clinic
VitroScan offers near clinical testing, capturing responses to drugs in the tumors native micro environment. Standardized procedures and high quality standards, lead to reproducible and reliable outcomes.
Download the brochure:
VitroScan predictive testing solutions
Closer to the clinic
High quality standards
Qualified scientists in cancer cell biology & bioinformatics